Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-20-002181

Director bought 30,000 shares at $0.69 ($20,700)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SAXE JON S Director 2020-08-21 Purchase +30,000 $0.69 $20,700 50,000 I
Open-market purchases · 30,000 sh · avg $0.69 · $20,700
Loading xslF345X03/form4-08242020_010800.xml…